Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Innospec (IOSP) EBT (2016 - 2025)

Innospec (IOSP) has disclosed EBT for 16 consecutive years, with -$61.9 million as the latest value for Q4 2025.

  • Quarterly EBT rose 67.89% to -$61.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $25.9 million through Dec 2025, up 152.86% year-over-year, with the annual reading at $25.9 million for FY2025, 152.86% up from the prior year.
  • EBT hit -$61.9 million in Q4 2025 for Innospec, down from $11.5 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $55.3 million in Q1 2024 to a low of -$192.8 million in Q4 2024.
  • Historically, EBT has averaged $19.6 million across 5 years, with a median of $41.2 million in 2021.
  • Biggest five-year swings in EBT: skyrocketed 236.86% in 2023 and later plummeted 525.61% in 2024.
  • Year by year, EBT stood at $32.7 million in 2021, then tumbled by 201.22% to -$33.1 million in 2022, then surged by 236.86% to $45.3 million in 2023, then tumbled by 525.61% to -$192.8 million in 2024, then skyrocketed by 67.89% to -$61.9 million in 2025.
  • Business Quant data shows EBT for IOSP at -$61.9 million in Q4 2025, $11.5 million in Q3 2025, and $31.9 million in Q2 2025.